322 related articles for article (PubMed ID: 19591920)
1. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor.
Rabbani ZN; Spasojevic I; Zhang X; Moeller BJ; Haberle S; Vasquez-Vivar J; Dewhirst MW; Vujaskovic Z; Batinic-Haberle I
Free Radic Biol Med; 2009 Oct; 47(7):992-1004. PubMed ID: 19591920
[TBL] [Abstract][Full Text] [Related]
2. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
[TBL] [Abstract][Full Text] [Related]
3. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
[TBL] [Abstract][Full Text] [Related]
4. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
[TBL] [Abstract][Full Text] [Related]
5. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I
Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142
[TBL] [Abstract][Full Text] [Related]
6. Thermal stability of the prototypical Mn porphyrin-based superoxide dismutase mimic and potent oxidative-stress redox modulator Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin chloride, MnTE-2-PyP(5+).
Pinto VH; Carvalhoda-Silva D; Santos JL; Weitner T; Fonseca MG; Yoshida MI; Idemori YM; Batinić-Haberle I; Rebouças JS
J Pharm Biomed Anal; 2013 Jan; 73():29-34. PubMed ID: 22503130
[TBL] [Abstract][Full Text] [Related]
7. Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities.
Batinic-Haberle I; Spasojevic I; Tse HM; Tovmasyan A; Rajic Z; St Clair DK; Vujaskovic Z; Dewhirst MW; Piganelli JD
Amino Acids; 2012 Jan; 42(1):95-113. PubMed ID: 20473774
[TBL] [Abstract][Full Text] [Related]
8. Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy.
Batinić-Haberle I; Cuzzocrea S; Rebouças JS; Ferrer-Sueta G; Mazzon E; Di Paola R; Radi R; Spasojević I; Benov L; Salvemini D
Free Radic Biol Med; 2009 Jan; 46(2):192-201. PubMed ID: 19007878
[TBL] [Abstract][Full Text] [Related]
9. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors.
Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I
Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403
[TBL] [Abstract][Full Text] [Related]
10. Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution.
Rebouças JS; Spasojević I; Tjahjono DH; Richaud A; Méndez F; Benov L; Batinić-Haberle I
Dalton Trans; 2008 Mar; (9):1233-42. PubMed ID: 18283384
[TBL] [Abstract][Full Text] [Related]
11. Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.
Jaramillo MC; Briehl MM; Batinic-Haberle I; Tome ME
Free Radic Biol Med; 2015 Jun; 83():89-100. PubMed ID: 25725417
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate.
Ye X; Fels D; Tovmasyan A; Aird KM; Dedeugd C; Allensworth JL; Kos I; Park W; Spasojevic I; Devi GR; Dewhirst MW; Leong KW; Batinic-Haberle I
Free Radic Res; 2011 Nov; 45(11-12):1289-306. PubMed ID: 21859376
[TBL] [Abstract][Full Text] [Related]
13. Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways.
Batinić-Haberle I; Ndengele MM; Cuzzocrea S; Rebouças JS; Spasojević I; Salvemini D
Free Radic Biol Med; 2009 Jan; 46(2):212-9. PubMed ID: 18983908
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP(5+), in plasma and major organs of B6C3F1 mice.
Spasojević I; Chen Y; Noel TJ; Fan P; Zhang L; Rebouças JS; St Clair DK; Batinić-Haberle I
Free Radic Biol Med; 2008 Oct; 45(7):943-9. PubMed ID: 18598757
[TBL] [Abstract][Full Text] [Related]
15. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins.
Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I
Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047
[TBL] [Abstract][Full Text] [Related]
16. Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes.
Rebouças JS; Spasojević I; Batinić-Haberle I
J Pharm Biomed Anal; 2008 Nov; 48(3):1046-9. PubMed ID: 18804338
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of the Antitumor and Radiosensitizing Effects of a Manganese Porphyrin, MnHex-2-PyP.
Shin SW; Choi C; Lee GH; Son A; Kim SH; Park HC; Batinic-Haberle I; Park W
Antioxid Redox Signal; 2017 Nov; 27(14):1067-1082. PubMed ID: 28358581
[TBL] [Abstract][Full Text] [Related]
18. Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage.
Gauter-Fleckenstein B; Fleckenstein K; Owzar K; Jiang C; Rebouças JS; Batinic-Haberle I; Vujaskovic Z
Free Radic Biol Med; 2010 Apr; 48(8):1034-43. PubMed ID: 20096348
[TBL] [Abstract][Full Text] [Related]
19. Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.
Tovmasyan A; Carballal S; Ghazaryan R; Melikyan L; Weitner T; Maia CG; Reboucas JS; Radi R; Spasojevic I; Benov L; Batinic-Haberle I
Inorg Chem; 2014 Nov; 53(21):11467-83. PubMed ID: 25333724
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant.
Mackensen GB; Patel M; Sheng H; Calvi CL; Batinic-Haberle I; Day BJ; Liang LP; Fridovich I; Crapo JD; Pearlstein RD; Warner DS
J Neurosci; 2001 Jul; 21(13):4582-92. PubMed ID: 11425886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
